CAMBRIDGE, Mass., April 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., announced today that it will report its financial results for the first quarter of 2008 on Tuesday, April 29, 2008 before the U.S. financial markets open.
In conjunction with the issuance of the press release, Idenix management will host a conference call at 8:30 a.m. ET on Tuesday, April 29, 2008 to discuss the company’s financial results for the first quarter 2008.
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and provide conference identification number 43988689 or to listen to a live audio webcast of the call, go to “Calendar of Events” in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from 11:30 a.m. ET on April 29, 2008 until 11:59 p.m. ET on May 13, 2008. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 43988689. An archived webcast will also be available for two weeks after the call on the Idenix website.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals’ Contact:
Media: Teri Dahlman (617) 995-9905
CONTACT: Teri Dahlman of Idenix Pharmaceuticals, Inc., +1-617-995-9905
Web site: http://www.idenix.com/
